-
-
Call more information
660-596-2224 -
Author: Michael Volkov JDSupra The Justice Department’s enforcement programs are resuming – False Claims Act, FCPA and other programs will continue. The rate of enforcement, however, is subject to change once again from the impact of the pandemic. As the pandemic continues to spread, DOJ focus on pandemic related fraud and other scams will divert […]
Read MoreThis is a great review for our pain readers. Author: Zawn Villines Medical News Today Hip pain can affect anyone. It can be a mild inconvenience or so severe that it interferes with daily functioning. Possible causes include muscle injury, osteoarthritis, and pelvic floor conditions. It can also occur during pregnancy. In this article, we […]
Read MoreAuthor: Kenneth R. DeVault, MD reviewing Almario CV et al. 2020 NEJM Journal Watch An online survey suggests a dose-dependent association between PPI use and risk for testing positive for COVID-19. Proton-pump inhibitors (PPIs) have become a mainstay in the treatment of acid-related conditions. They were initially felt to be very safe, but multiple studies published in the […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Rapid reperfusion is linked to improved survival for STEMI patients, a point confirmed again and again by numerous studies and clinical guidelines. Delayed care is still prevalent, however, especially when the patient presents at a facility where percutaneous coronary intervention (PCI) is unavailable and transportation is required. The authors […]
Read MoreDG Alerts Results from an Italian study published in The Lancet Rheumatology have demonstrated a significant reduction in the risk of invasive mechanical ventilation or death in patients with severe coronavirus disease 2019 (COVID-19) pneumonia who were treated with the IL-6 inhibitor tocilizumab, either intravenously or subcutaneously, when compared with standard care. The authors said the association […]
Read More